Additional studies in an orthotopic MB49 bladder cancer model showcased significant tumor regression with NHS-IL12 associated with decreases in immunosuppressive tumor TGFβ levels, MDSCs and TAMs, while increasing M1-macrophages and CD4+ and CD8+ T cell responses (17, 36). This evidence concerns the gene CD4 and neoplasm.